However, CHI3L1, as well as phosphorylated tau and phosphorylated tau/Aβ and total tau/Aβ combinations, have a predictive value of cognitive decline in PD during follow-up, as revealed by correlating CSF levels with cognitive measurements. The gene discussed is MAPT; the disease is Parkinson disease.